إعلان
إعلان
JBIO
J
Jade Biosciences, Inc. Common Stock
13.53
USDبرعاية
+0.28
+2.13%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
13.53
0.00
0.00%
تقارير أرباح JBIO
النسبة الإيجابية المفاجئة
JBIO تفوق 6 من 18 آخر التقديرات.
33%
التقرير التالي
بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.52
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+8.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-92.18%
Jade Biosciences, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, JBIO reported earnings of -0.48 USD per share (EPS) for Q3 25, beating the estimate of -0.68 USD, resulting in a 30.18% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +10.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an زيادة of 8.33% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Jade Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Jade Biosciences, Inc. Common Stock reported EPS of -$0.48, beating estimates by 30.18%, and revenue of $0.00, 0% as expectations.
How did the market react to Jade Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 10.54%, changed from $9.68 before the earnings release to $10.70 the day after.
When is Jade Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
What are the forecasts for Jade Biosciences, Inc. Common Stock's next earnings report?
Based on 9
المحللين, Jade Biosciences, Inc. Common Stock is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان